Clinical Trial Update: Efficacy Study of GLYC-101 to Evaluate Outcomes After Post-laser Ablation [Phase 1, Phase 2]

View source ↗

Summary

A combined Phase 1/2 clinical trial evaluating GLYC-101 for outcomes after post-laser ablation in wounds has completed with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wounds

Drugs mentioned

• GLYC-101

Snippet

Sponsor: TR Therapeutics | Conditions: Wounds | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2011-07-25